NCT00950365 - Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 17, 2017

Study Completion Date

November 17, 2017

Conditions

Bronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer

Interventions

DRUG

Erlotinib Hydrochloride

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Pemetrexed Disodium

Given IV

Trial Locations (5)

10461

Albert Einstein College of Medicine, The Bronx

10467

Bronx River Medical Associates PC, The Bronx

10469

Eastchester Center for Cancer Care, The Bronx

95817

University of California Davis Comprehensive Cancer Center, Sacramento

01605

University of Massachusetts Memorial Health Care, Worcester